Salivary blockade protects the lower respiratory tract of mice from lethal influenza virus infection

Journal of Virology

Volumn 91, Issue 14, 2017, Pages

  Ivinson, Karen ^a,b   Deliyannis, Georgia ^a   McNabb, Leanne ^a,c   Grollo, Lara ^a,d   Gilbertson, Brad ^a   Jackson, David ^a   Brown, Lorena E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PATH Malaria Vaccine Initiative   (Switzerland)

^c CSIRO   (Australia)

^d AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

Author keywords

Influenza; Innate inhibitors

Indexed keywords

CARBOHYDRATE; SIALIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA; INFLUENZA A; INFLUENZA A VIRUS (A/PUERTO RICO/8/1934(H1N1)); INFLUENZA B; LOWER RESPIRATORY TRACT INFECTION; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALIVA; TRACHEA; VIRUS NEUTRALIZATION; VIRUS STRAIN; VIRUS TITRATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DISEASE MODEL; IMMUNOLOGY; INFLUENZA A VIRUS; INNATE IMMUNITY; NOSE CAVITY; ORTHOMYXOVIRUS INFECTION; RESPIRATORY TRACT INFECTION; SCID MOUSE; VIROLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; IMMUNITY, INNATE; INFLUENZA A VIRUS; LUNG; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; NASAL CAVITY; ORTHOMYXOVIRIDAE INFECTIONS; RESPIRATORY TRACT INFECTIONS; SALIVA; TRACHEA;

EID: 85021201482     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00624-17     Document Type: Article

References (35)

1. Hartshorn KL, Crouch EC, White MR, Eggleton P, Tauber AI, Chang D, Sastry K. 1994. Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J Clin Invest 94:311-319. https://doi.org/10.1172/JCI117323
2. Hartshorn KL, Liou LS, White MR, Kazhdan MM, Tauber JL, Tauber AI. 1995. Neutrophil deactivation by influenza A virus. Role of hemagglutinin binding to specific sialic acid-bearing cellular proteins. J Immunol 154:3952-3960
3. Hartshorn KL, Reid KB, White MR, Jensenius JC, Morris SM, Tauber AI, Crouch E. 1996. Neutrophil deactivation by influenza A viruses: mechanisms of protection after viral opsonization with collectins and hemagglutination-inhibiting antibodies. Blood 87:3450-3461
4. Hartshorn KL, White MR, Mogues T, Ligtenberg T, Crouch E, Holmskov U. 2003. Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses. Am J Physiol Lung Cell Mol Physiol 285:L1066-L1076. https://doi.org/10.1152/ajplung.00057 .2003
5. Hartshorn KL, White MR, Shepherd V, Reid K, Jensenius JC, Crouch EC. 1997. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am J Physiol 273:L1156-L1166
6. Hartshorn KL, White MR, Tecle T, Holmskov U, Crouch EC. 2006. Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D. J Immunol 176:6962-6972. https://doi.org/10.4049/jimmunol.176.11.6962
7. White MR, Crouch E, van Eijk M, Hartshorn M, Pemberton L, Tornoe I, Holmskov U, Hartshorn KL. 2005. Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitor. Am J Physiol Lung Cell Mol Physiol 288:L831-L840. https://doi.org/10.1152/ajplung.00365.2004
8. Anders EM, Hartley CA, Jackson DC. 1990. Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins. Proc Natl Acad Sci U S A 87:4485-4489. https://doi.org/10.1073/pnas.87.12.4485
9. Reading PC, Morey LS, Crouch EC, Anders EM. 1997. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol 71:8204-8212
10. Hartshorn KL, Sastry K, Brown D, White MR, Okarma TB, Lee YM, Tauber AI. 1993. Conglutinin acts as an opsonin for influenza-A viruses. J Immunol 151:6265-6273
11. Hartshorn KL, Sastry K, White MR, Anders EM, Super M, Ezekowitz RA, Tauber AI. 1993. Human mannose-binding protein functions as an opsonin for influenza-A viruses. J Clin Invest 91:1414-1420. https://doi.org/10.1172/JCI116345
12. Anders EM, Hartley CA, Reading PC, Ezekowitz RA. 1994. Complementdependent neutralization of influenza virus by a serum mannosebinding lectin. J Gen Virol 75:615-622. https://doi.org/10.1099/0022-1317-75-3-615
13. Hanaoka K, Pritchett TJ, Takasaki S, Kochibe N, Sabesan S, Paulson JC, Kobata A. 1989. 4-O-acetyl-N-acetylneuraminic acid in the N-linked carbohydrate structures of equine and guinea pig alpha 2-macroglobulins, potent inhibitors of influenza virus infection. J Biol Chem 264: 9842-9849
14. Pritchett TJ, Paulson JC. 1989. Basis for the potent inhibition of influenzavirus infection by equine and guinea-pig alpha-2-macroglobulin. J Biol Chem 264:9850-9858
15. Benne CA, Kraaijeveld CA, Vanstrijp JAG, Brouwer E, Harmsen M, Verhoef J, Vangolde LMG, Vaniwaarden JF. 1995. Interactions of surfactant protein-A with influenza-A viruses; binding and neutralization. J Infect Dis 171:335-341. https://doi.org/10.1093/infdis/171.2.335
16. Reading PC, Bozza S, Gilbertson B, Tate M, Moretti S, Job ER, Crouch EC, Brooks AG, Brown LE, Bottazzi B, Romani L, Mantovani A. 2008. Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J Immunol 180:3391-3398. https://doi.org/10.4049/jimmunol.180.5.3391
17. Iida T, Bang FB. 1963. Infection of the upper respiratory tract of mice with influenza A virus. Am J Hyg 77:169-176
18. Yetter RA, Lehrer S, Ramphal R, Small PA, Jr. 1980. Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infect Immun 29:654-662
19. Novak M, Moldoveanu Z, Schafer DP, Mestecky J, Compans RW. 1993. Murine model for evaluation of protective immunity to influenza virus. Vaccine 11:55-60. https://doi.org/10.1016/0264-410X(93)90339-Y
20. Koerner I, Matrosovich MN, Haller O, Staeheli P, Kochs G. 2012. Altered receptor specificity and fusion activity of the haemagglutinin contribute to high virulence of a mouse-adapted influenza A virus. J Gen Virol 93:970-979. https://doi.org/10.1099/vir.0.035782-0
21. Pekosz A, Newby C, Bose PS, Lutz A. 2009. Sialic acid recognition is a key determinant of influenza A virus tropism in murine trachea epithelial cell cultures. Virology 386:61-67. https://doi.org/10.1016/j.virol.2009.01.005
22. Rogers GN, Paulson JC. 1983. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127:361-373. https://doi.org/10.1016/0042-6822(83)90150-2
23. Hartley CA, Jackson DC, Anders EM. 1992. Two distinct serum mannosebinding lectins function as beta inhibitors of influenza virus: identification of bovine serum beta inhibitor as conglutinin. J Virol 66:4358-4363
24. Malamud D, Abrams WR, Barber CA, Weissman D, Rehtanz M, Golub E. 2011. Antiviral activities in human saliva. Adv Dent Res 23:34-37. https://doi.org/10.1177/0022034511399282
25. White MR, Helmerhorst EJ, Ligtenberg A, Karpel M, Tecle T, Siqueira WL, Oppenheim FG, Hartshorn KL. 2009. Multiple components contribute to ability of saliva to inhibit influenza viruses. Oral Microbiol Immunol 24:18-24. https://doi.org/10.1111/j.1399-302X.2008.00468.x
26. Cohen M, Zhang XQ, Senaati HP, Chen HW, Varki NM, Schooley RT, Gagneux P. 2013. Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase. Virol J 10:321. https://doi.org/10.1186/1743-422X-10-321
27. White MR, Crouch E, Vesona J, Tacken PJ, Batenburg JJ, Leth-Larsen R, Holmskov U, Hartshorn KL. 2005. Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus. Am J Physiol Lung Cell Mol Physiol 289:L606-L616. https://doi.org/10.1152/ajplung.00130.2005
28. Haller O, Acklin M, Staeheli P. 1987. Influenza virus resistance of wild mice: wild-type and mutant Mx alleles occur at comparable frequencies. J Interferon Res 7:647-656. https://doi.org/10.1089/jir.1987.7.647
29. Edenborough KM, Gilbertson BP, Brown LE. 2012. A mouse model for the study of contact-dependent transmission of influenza A virus and the factors that govern transmissibility. J Virol 86:12544-12551. https://doi .org/10.1128/JVI.00859-12
30. Gilbertson B, Ng WC, Crawford S, McKimm-Breschkin JL, Brown LE. Mouse saliva inhibits transit of influenza virus to the lower respiratory tract by efficiently blocking influenza virus neuraminidase activity. J Virol 91:e00145-17
31. Kilbourne ED. 1969. Future influenza vaccines and the use of genetic recombinants. Bull World Health Organ 41:643-645
32. Baez M, Palese P, Kilbourne ED. 1980. Gene composition of high-yielding influenza vaccine strains obtained by recombination. J Infect Dis 141: 362-365. https://doi.org/10.1093/infdis/141.3.362
33. Xu X, Kilbourne ED, Hall HE, Cox NJ. 1994. Nonimmunoselected intrastrain genetic variation detected in pairs of high-yielding influenza A (H3N2) vaccine and parental viruses. J Infect Dis 170:1432-1438. https://doi.org/10.1093/infdis/170.6.1432
34. Anders EM, Scalzo AA, Rogers GN, White DO. 1986. Relationship between mitogenic activity of influenza viruses and the receptor-binding specificity of their hemagglutinin molecules. J Virol 60:476-482
35. Tannock GA, Paul JA, Barry RD. 1984. Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Infect Immun 43:457-462